Pressures and Strategic Imperatives of Resiliency: Rethinking Pharma Supply Chains

Geopolitical fragmentation and resource nationalism are actively reshaping sourcing strategies for medicine manufacturers, forcing companies to balance the need for resilience with cost efficiency and trade concerns. Facing another market realignment, companies are also experiencing political pressure from governments across the Americas, Europe, and Asia, as they introduce policies that seek to secure domestic access to critical medicines. These factors are working to create immediate pressure to reconfigure long-established supply networks, regardless of existing national or regional demand. This session addresses the operational complexity of translating policy ambitions into practical supply chain changes.